Drug Interaction Report

Clindamycin and Nirogacestat: Interaction Details

AI-assisted, pharmacist-reviewed · AI content regenerated Jul 11, 2026 · Source data updated Jul 1, 2026 · Sources: FDA labeling, DDInter 2.0, cited literature

Clindamycin

ANTIROBE Cleocin Cleocin-T Cleocin® Clinda-Guard Clindacin ClindaCure Clindagel
+

Nirogacestat

Ogsiveo
Dr. Brian Staiger, PharmD, BCPS
Medically reviewed by
Updated Jul 1, 2026
LinkedIn
Interaction severity
Major
Potentially serious — often needs a change or close monitoring.
How we grade severity & evidence

Severity levels

  • Contraindicated: These should generally not be used together.
  • Major: Potentially serious — often needs a change or close monitoring.
  • Moderate: Can be significant — usually manageable with monitoring.
  • Minor: Usually limited clinical impact.

Evidence grades

  • Established: Well documented — supported by controlled studies or strong clinical data.
  • Probable: Good supporting evidence, though not definitively proven.
  • Suspected: Some evidence suggests this interaction, but it is not well established.
  • Possible: Limited or conflicting evidence; the interaction may occur.
  • Theoretical: Predicted from the drugs' pharmacology; not yet confirmed in people.

Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.

Of 84 documented Clindamycin interactions, 61 are rated major — including this one.
Worried about symptoms right now? Contact your pharmacist or prescriber, or call Poison Control at 1-800-222-1222 (US). Call 911 for an emergency.
At a glance + Effects may be stronger
The Bottom Line
Nirogacestat can raise clindamycin levels by blocking CYP3A, so the label advises avoiding this combination when possible. Don't change anything on your own; ask your pharmacist or doctor whether a different antibiotic is a better fit.

Here's what's going on with these two medicines. Nirogacestat (Ogsiveo) slows down a liver enzyme called CYP3A that your body uses to break down many drugs, including clindamycin. When that enzyme is blocked, clindamycin can build up higher than usual in your body, which may raise your chance of side effects like stomach upset, diarrhea, or other reactions.

The good news is that this is very manageable. Your care team knows about this interaction and can plan for it, whether that means choosing a different antibiotic, adjusting things, or watching you a little more closely. Please don't stop or change either medicine on your own. Just talk with your pharmacist or doctor so they can guide you.

Effect: Nirogacestat inhibits CYP3A, reducing metabolism of CYP3A substrates and increasing their systemic exposure with a higher risk of substrate-related adverse effects.

  • Direction: Increased clindamycin exposure (clindamycin is partly CYP3A4-metabolized).
  • Magnitude: Not established for clindamycin. For midazolam (index CYP3A substrate), nirogacestat 150 mg BID is predicted to raise Cmax ~1.77-fold and AUC ~2.07-fold.
  • Evidence / onset: Probable; onset unspecified.
  • Management: Label advises avoiding concomitant use of nirogacestat with CYP3A substrates. Consider a non-CYP3A alternative antibiotic; if co-use is unavoidable, monitor closely for clindamycin-related adverse effects. Dose may need individualization by the care team.
Onset
unspecified
Evidence
probable
Severity
Major

What happens

Increased CYP3A substrate exposure and an increased risk of CYP3A substrate-related adverse effects

Interaction Deep Dive

Do not administer nirogacestat together with CYP3A substrates. Because nirogacestat raises the exposure of CYP3A substrates, even small changes in their concentrations can produce serious adverse reactions. When taken alongside multiple doses of nirogacestat (150 mg twice daily), the Cmax of midazolam (a CYP3A substrate) is projected to rise by 1.77-fold and its AUC by 2.07-fold1.

Why it happens (mechanism)

Inhibition of CYP3A-substrate metabolism by nirogacestat

How to manage this interaction

What your care team may do:

  • Consider whether a different antibiotic that isn't affected by nirogacestat would work for your infection.
  • If both are needed, monitor you more closely for side effects such as GI upset or diarrhea.
  • Adjust and individualize your therapy as appropriate for you.

What you should do:

  • Keep taking both medicines exactly as prescribed unless your prescriber tells you otherwise.
  • Tell your pharmacist or doctor you're on both drugs, and report any new or worsening side effects.

Management is individual — confirm any change with your pharmacist or prescriber.

Literature reports

1 report — tap to read

a) When taken together with repeated doses of nirogacestat (150 mg twice daily), the Cmax of midazolam (a CYP3A substrate) is projected to rise by 1.77-fold and its AUC by 2.07-fold 1.

Common questions

Can I take Clindamycin and Nirogacestat together?

Nirogacestat can raise clindamycin levels by blocking CYP3A, so the label advises avoiding this combination when possible. Don't change anything on your own; ask your pharmacist or doctor whether a different antibiotic is a better fit. Always confirm with your pharmacist or prescriber before making any change.

How serious is the Clindamycin and Nirogacestat interaction?

It is rated major. Potentially serious — often needs a change or close monitoring.

How quickly could this interaction happen?

The documented onset is "unspecified". The timing of this interaction is not well characterized.

How is the Clindamycin and Nirogacestat interaction managed?

What your care team may do: Consider whether a different antibiotic that isn't affected by nirogacestat would work for your infection. If both are needed, monitor you more closely for side effects such as GI upset or diarrhea. Adjust and individualize your therapy as appropriate for you. What you should do: Keep taking both medicines exactly as prescribed unless your prescriber tells you otherwise… Management is individual — always follow your own care team's guidance.

How strong is the evidence for this interaction?

The evidence is graded "probable". Good supporting evidence, though not definitively proven.

Questions for your pharmacist

  • Does my dose of Clindamycin or Nirogacestat need adjusting while I take them together?
  • What symptoms should prompt me to call you or my prescriber right away?
  • Does the timing of my doses matter for this combination?
  • Is there a safer alternative to one of these medications for me?

References (1)

  1. Product Information: OGSIVEO(TM) oral tablets, nirogacestat oral tablets. SpringWorks Therapeutics, Inc. (per FDA), Stamford, CT, 2023. DailyMed
Was this write-up helpful?
Beyond drug–drug

These medications also interact with supplements

Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:

major · moderate · minor — check everything you take with our drug–supplement interaction checker.

Check another combination

Our instant two-drug interaction checker is almost here.

Coming soon

The instant two-drug checker is on its way.

In the meantime, browse the directory below to look up any drug and see its documented interactions.

Still have questions about this combination?

Every question gets a real answer from a licensed pharmacist — free, and usually within a day.

Ask the pharmacist
This information is for education, not a substitute for professional medical advice. Do not start, stop, or change any medication without talking to your pharmacist or prescriber.